Loading...
•
Sep 30, 2024
Glaukos Q3 2024 Earnings Report
Glaukos' third quarter results for 2024 reflected strong performance with record net sales and successful execution of strategic plans.
Key Takeaways
Glaukos Corporation reported record net sales of $96.7 million for the third quarter of 2024, a 24% increase year-over-year. The company's glaucoma sales reached $76.0 million, up 30% year-over-year, while corneal health sales increased by 5% to $20.6 million. The company raised its 2024 net sales guidance to $377 million to $379 million.
Record net sales of $96.7 million, a 24% increase year-over-year.
Glaucoma net sales reached a record $76.0 million, up 30% year-over-year.
Corneal Health net sales increased by 5% year-over-year to $20.6 million.
2024 net sales guidance raised to $377 million - $379 million.
Revenue by Geographic Location
Forward Guidance
The company expects 2024 net sales to be in the range of $377 million to $379 million based on the latest foreign currency exchange rates.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...